Levosimendan in the Treatment of Patients with Severe Septic Cardiomyopathy

(1) Background: The optimal treatment of septic cardiomyopathy (SCM) remains questionable. The aim of the study was to compare the treatment of SCM based on levosimendan versus the best available therapy. (2) Methods: We conducted an observational study including patients with severe septic cardiomy...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsolaki, Vasiliki, Zakynthinos, George E., Papanikolaou, John, Vazgiourakis, Vasileios, Parisi, Kyriaki, Fotakopoulos, George, Makris, Demosthenes, Zakynthinos, Epaminondas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303716/
https://www.ncbi.nlm.nih.gov/pubmed/37374128
http://dx.doi.org/10.3390/life13061346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303716/
https://www.ncbi.nlm.nih.gov/pubmed/37374128
http://dx.doi.org/10.3390/life13061346

Ejemplares similares